| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| OrbiMed Capital GP VIII LLC | Director, 10%+ Owner | $1.24M | Feb 17, 2023 | ||
| Richard Thomas Williams | Chief Medical Officer | $175K | Mar 1, 2024 | ||
| Mark A. Meltz | Coo General Counsel Secretary | $0 | Apr 3, 2024 | ||
| Keith T. Flaherty | Director | $0 | Apr 3, 2024 | ||
| James B. Tananbaum | Director, 10%+ Owner | $0 | Apr 3, 2024 | ||
| Orbimed Advisors Llc | Director, 10%+ Owner | $0 | Apr 3, 2024 | ||
| Foresite Capital Management IV, LLC | 10%+ Owner | $0 | Apr 3, 2024 | ||
| Neha Krishnamohan | Chief Financial Officer | $0 | Apr 3, 2024 | ||
| Nima Farzan | CHIEF EXECUTIVE OFFICER, Director | $0 | Apr 3, 2024 | ||
| Carl L. Gordon | Director, 10%+ Owner | $0 | Apr 3, 2024 | ||
| Laurie Smaldone | Director | Apr 3, 2024 | |||
| Michael E. Rome | Director | Apr 3, 2024 | |||
| Melissa Epperly | Director | Apr 3, 2024 | |||
| Dean J. Mitchell | Director | Apr 3, 2024 | |||
| Jill DeSimone | Director | Apr 3, 2024 | |||
| Helen Sabzevari | Director | Apr 3, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|